Eur Heart J:不明原因心脏骤停的特点及临床评估!

2018-03-18 xing.T MedSci原创

该研究结果表明,全面调查是在很小一部分原因不明的SCA患者中进行的。需要实施标准化、系统化的方法,以确保不错过特定治疗和预防战略(包括亲属)的机会。

最近的研究表明,超过半数的突发心脏骤停(SCA)患者原因不明,特定的病因通过仔细评估可以揭露。在实际生活中通过系统深入调查这些病例的特点和程度仍是未知的。

近日,心血管领域权威杂志Eur Heart J上发表了一篇研究文章,研究人员从正在进行的收集巴黎地区所有院外心脏骤停病例的研究中分析了数据。在住院期间或出院后计划进行的调查中收集了对不明原因SCA的完整性评估。

在2011年至2016年期间,其中有18622例院外的心脏骤停患者,717名幸存者(出院时)完成心脏SCA定义。其中,88例(12.3%)在心电图、超声心动图和冠状动脉造影术后仍无法解释病因。心脏磁共振成像诊断了25例(3.5%)患者, 14例(2.4%)在其他调查中有额外的诊断,49例(6.8%)患者被诊断为特发性心室颤动(IVF)(48.7 ± 15 岁,69.4%为男性)。这些诊断为IVF患者,只有8例(16.3%)患者受益于完整的检查(包括药理试验)。对较年轻的患者[比值比(OR)为6,95%可信区间(CI)为1.80 - 22.26]和那些进入大学医疗中心(OR为3.60,95%CI为1.12 - 12.45)的患者进行更深入的调查。分别在9例(18.4%)和12例(24.5%)患者中进行了基因检测和家庭筛查

该研究结果表明,全面调查是在很小一部分原因不明的SCA患者中进行的。需要实施标准化、系统化的方法,以确保不错过特定治疗和预防战略(包括亲属)的机会。

原始出处:

Victor Waldmann,et al. Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation. Eur Heart J.2018. https://doi.org/10.1093/eurheartj/ehy098

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1740899, encodeId=f7721e408996b, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Jun 02 18:24:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299504, encodeId=529529950489, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 25 09:20:26 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356740, encodeId=ccfd1356e402d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562874, encodeId=02cc15628e434, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297457, encodeId=0b0129e4578d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Mar 18 19:10:26 CST 2018, time=2018-03-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1740899, encodeId=f7721e408996b, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Jun 02 18:24:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299504, encodeId=529529950489, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 25 09:20:26 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356740, encodeId=ccfd1356e402d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562874, encodeId=02cc15628e434, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297457, encodeId=0b0129e4578d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Mar 18 19:10:26 CST 2018, time=2018-03-18, status=1, ipAttribution=)]
    2018-03-25 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1740899, encodeId=f7721e408996b, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Jun 02 18:24:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299504, encodeId=529529950489, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 25 09:20:26 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356740, encodeId=ccfd1356e402d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562874, encodeId=02cc15628e434, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297457, encodeId=0b0129e4578d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Mar 18 19:10:26 CST 2018, time=2018-03-18, status=1, ipAttribution=)]
    2018-03-20 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1740899, encodeId=f7721e408996b, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Jun 02 18:24:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299504, encodeId=529529950489, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 25 09:20:26 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356740, encodeId=ccfd1356e402d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562874, encodeId=02cc15628e434, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297457, encodeId=0b0129e4578d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Mar 18 19:10:26 CST 2018, time=2018-03-18, status=1, ipAttribution=)]
    2018-03-20 slcumt
  5. [GetPortalCommentsPageByObjectIdResponse(id=1740899, encodeId=f7721e408996b, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Jun 02 18:24:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299504, encodeId=529529950489, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 25 09:20:26 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356740, encodeId=ccfd1356e402d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562874, encodeId=02cc15628e434, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Mar 20 04:24:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297457, encodeId=0b0129e4578d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Mar 18 19:10:26 CST 2018, time=2018-03-18, status=1, ipAttribution=)]
    2018-03-18 忠诚向上

    好好学习天天向上

    0

相关资讯

N Engl J Med:关注竞技体育期间的心搏骤停

近期,《新英格兰医学杂志》发表一项最新回顾性研究,评估了年轻运动员竞技体育期间心搏骤停(SCA)的发生率。

J Periodontal Res:镰状细胞性贫血以及镰刀形细胞性状是否可用于用于预测牙周病的发生?

牙周病的发生是细菌侵入以及宿主免疫反应共同造成的,同时也受遗传因素的影响。有研究表明,镰状细胞性贫血(SCA)并不是牙周病发生的危险因素。但是,目前对于杂合子状态下的镰刀形细胞性状(SCL)与牙周炎之间是否存在某种关系则尚未清楚。SCT是一种可引起血管闭塞性事件发生的遗传性疾病,血管闭塞性疾病或与细菌的感染有关。本研究旨在通过临床和影像学特点的评估来探究SCA及SCT与牙周病之间的关联。